The Immune System – News and Features

A new systematic review reveals that rapamycin – a compound originally developed as an immunosuppressant – can deliver comparable life-extending effects in eight different vertebrate species.

A vaccine developed by University of Georgia researchers successfully protects against and treats vaginal yeast infections in mice, according to a newly published study.

New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays, which can last decades in diagnosing lupus, an autoimmune condition.

Researchers have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants – materials that help stimulate the immune system.

Disrupting the body’s internal clock during adolescence can alter how the brain responds to an in-utero risk factor linked to certain brain disorders, a new mouse study suggests.

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.

Single-cell analysis of brain tissue has revealed genome alterations linked to PTSD, offering insights into targeted treatments.

A new approach induces the patient’s body to produce its own CAR-T cells, relying on the same messenger RNA (mRNA) technology that was instrumental for some COVID-19 vaccines.

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma who have different levels of benefit from CD19 CAR T-Cell Therapy.